Seres Therapeutics, Inc.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Mar 2017 | — | -858.7% | -844.9% |
| Jun 2017 | — | -942.8% | -929.6% |
| Sep 2017 | — | -31.8% | -30.1% |
| Mar 2018 | — | -711.8% | -703.1% |
| Jun 2018 | — | -610.1% | -602.5% |
| Sep 2018 | — | -245.3% | -242.4% |
| Mar 2019 | — | -335.4% | -332.4% |
| Jun 2019 | — | -87.4% | -85.9% |
| Sep 2019 | — | -244.4% | -233.4% |
| Mar 2020 | — | -240.5% | -242.8% |
| Jun 2020 | — | -339.9% | -342.7% |
| Sep 2020 | — | -2,116.8% | -2,136.9% |
| Mar 2021 | — | -617.8% | -620.2% |
| Jun 2021 | — | -914.7% | -918.3% |
| Sep 2021 | — | 54.0% | 53.8% |
| Mar 2022 | — | -3,734.2% | -3,792.6% |
| Jun 2022 | — | -5,207.6% | -5,323.6% |
| Sep 2022 | — | -1,716.2% | -1,742.2% |
| Mar 2023 | — | 13,518.8% | 13,634.9% |
| Jun 2023 | — | 39.2% | 36.8% |
| Sep 2023 | — | -14,382.6% | -15,436.8% |
| Sep 2025 | — | -6,403.7% | 2,337.3% |
| Mar 2026 | — | -5,839.9% | -5,562.3% |
| Jun 2026 | — | -2,890.4% | 622.4% |